title: Attenuation of interleukin-8 production by inhibiting nuclear factor-kappaB translocation using decoy oligonucleotides.
abstract: Interleukin-8 (IL-8), a monocyte-derived neutrophil chemoattractant factor, is a polymorphonuclear neutrophil chemotaxin that is involved in a number of inflammatory disorders. Transcription of the IL-8 gene is controlled by regulatory proteins, including nuclear factor-kappaB (NF-kappaB), a family of proteins that is important in the transcriptional control of a number of genes. When cells are activated, NF-kappaB translocates from the cytoplasm to the nucleus, where it activates transcription by binding to a specific sequence within the 5' untranslated region of the gene. During translocation, NF-kappaB is potentially susceptible to diversion by oligonucleotides that contain the binding sequence for this protein. In the current study, we produced phosphorothioate-modified oligonucleotides containing the specific DNA sequence that NF-kappaB binds within the IL-8 gene. We then investigated the effects of transfection of monocytes with these oligonucleotides on interleukin-1beta (IL-1beta)-stimulated IL-8 production, IL-8 mRNA expression, and NF-kappaB binding activity. We found that transfection with these oligonucleotides significantly inhibited monocyte IL-8 production. A single-stranded oligonucleotide with two copies of the NF-kappaB-binding sequence was the most potent of those tested. This single-stranded oligonucleotide also inhibited IL-1beta-induced translocation of NF-kappaB to the nucleus and reduced IL-8 mRNA expression. These studies demonstrated that monocyte production of IL-8 can be attenuated using a single-stranded oligonucleotide that binds a transcriptional activating protein before it translocates to the cell nucleus. This approach ultimately may be useful in the control of inflammation involved in a number of diseases.
authors.affiliation: Pulmonary Sections, Birmingham Veterans Affairs Medical Center, Birmingham, AL 35233, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Cooper
authors.forename: J M
authors.initials: JM
authors.lastname: Parks
authors.forename: R
authors.initials: R
authors.lastname: Carcelen
authors.forename: S S
authors.initials: SS
authors.lastname: Kahlon
authors.forename: M
authors.initials: M
authors.lastname: Sheffield
authors.forename: R
authors.initials: R
authors.lastname: Culbreth
mesh_terms: D001667:Binding, Competitive; D001692:Biological Transport / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D016384:Consensus Sequence; D006801:Humans; D066298:In Vitro Techniques; D016209:Interleukin-8 / Q000096:biosynthesis* / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D016328:NF-kappa B / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D009841:Oligonucleotides / Q000235:genetics / Q000494:pharmacology*; D010714:Phosphatidylethanolamines / Q000494:pharmacology; D011485:Protein Binding; D012333:RNA, Messenger / Q000378:metabolism; D013347:Subcellular Fractions; D014162:Transfection
chemical_list: D016209:Interleukin-8; D016328:NF-kappa B; D009841:Oligonucleotides; D010714:Phosphatidylethanolamines; D012333:RNA, Messenger; C020888:1,2-dielaidoylphosphatidylethanolamine